Can hyperglycemia (elevated blood glucose), indicated by a fasting blood glucose of 153 mg/dL and a Hemoglobin A1c (HbA1c) of 5.7%, along with hypogonadism (low testosterone) of 153 ng/dL, cause elevated Follicle-Stimulating Hormone (FSH) of 31 mIU/mL and Luteinizing Hormone (LH) of 13.7 mIU/mL in a 51-year-old male?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The elevated FSH (31) and LH (13.7) in this 51-year-old male are most likely indicative of primary hypogonadism, which is not directly caused by his mildly elevated fasting blood glucose (153) or borderline A1c (5.7), nor by his low testosterone (153) alone, as suggested by the most recent guidelines 1. The patient's hormonal profile, characterized by high FSH and LH levels alongside low testosterone, points towards testicular failure rather than a problem with the pituitary or hypothalamus. This condition is known as primary hypogonadism. When testosterone levels are low, the brain's pituitary gland naturally increases FSH and LH production to stimulate the testes to produce more testosterone. The pattern of high FSH/LH with low testosterone indicates testicular failure rather than a problem with the pituitary or hypothalamus. Key considerations in managing this patient include:

  • Referral to an endocrinologist for further evaluation, which may include testicular ultrasound, karyotype testing, and assessment for other causes of primary hypogonadism such as Klinefelter syndrome, prior trauma, infection, or radiation exposure, as recommended by recent clinical practice guidelines 1.
  • Treatment typically involves testosterone replacement therapy, which would need to be carefully monitored, with consideration of the potential benefits and risks as outlined in recent evidence reports 1.
  • The prediabetic state (indicated by the glucose and A1c values) should be addressed separately with lifestyle modifications and possibly metformin, but it is not the cause of the hormonal imbalance, as suggested by standards of medical care in diabetes 1. Given the complexity of this case and the need for specialized care, the patient should be managed under the guidance of an endocrinologist to ensure appropriate diagnosis and treatment of both the hormonal imbalance and the prediabetic condition, prioritizing morbidity, mortality, and quality of life outcomes.

From the Research

Hormonal Imbalance and Testosterone Replacement Therapy

The patient's low testosterone level of 153, combined with an elevated FSH of 31 and LH of 13.7, may indicate primary hypogonadism 2. In this condition, the testes do not produce enough testosterone, leading to an increase in FSH and LH levels as the pituitary gland tries to stimulate testosterone production.

Relationship Between Testosterone and FSH/LH Levels

  • FSH and LH are gonadotropins that regulate testosterone production in the testes.
  • Elevated FSH and LH levels can indicate primary hypogonadism, where the testes are not responding to gonadotropin stimulation 2.
  • Testosterone replacement therapy (TRT) may be considered to alleviate symptoms of hypogonadism, but it can also suppress FSH and LH production 3, 4.

Impact of Testosterone Replacement Therapy on FSH and LH Levels

  • TRT can induce reversible suppression of spermatogenesis, which may affect FSH and LH levels 2.
  • The use of TRT in hypogonadal men can improve symptoms and quality of life, but its effects on FSH and LH levels should be closely monitored 5, 6.

Considerations for Diagnosis and Treatment

  • A comprehensive diagnosis of hypogonadism should include assessment of testosterone levels, FSH, LH, and other hormonal parameters 3, 6.
  • Treatment with TRT should be individualized, taking into account the patient's symptoms, medical history, and potential risks and benefits 4, 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Testosterone Replacement Therapy in Hypogonadal Men.

Endocrinology and metabolism clinics of North America, 2022

Research

Hypogonadism: Therapeutic Risks, Benefits, and Outcomes.

The Medical clinics of North America, 2018

Research

Testosterone replacement therapy.

Andrology, 2020

Related Questions

Can hyperglycemia (elevated blood glucose), indicated by a fasting blood glucose of 153 mg/dL and a Hemoglobin A1c (HbA1c) of 5.7%, along with hypogonadism (low testosterone) of 153 ng/dL, cause elevated Follicle-Stimulating Hormone (FSH) of 31 mIU/mL and Luteinizing Hormone (LH) of 13.7 mIU/mL in a 51-year-old male?
What is the treatment approach for a patient with low Sex Hormone-Binding Globulin (SHBG) and low bioavailable testosterone?
What are the formulations of Hormone Replacement Therapy (HRT)?
What are the indications for testosterone replacement therapy (TRT) workup?
Should testosterone replacement therapy (TRT) be continued perioperatively?
What are the management options for a 64-year-old male with hypertension and dyslipidemia, admitted for pancreatitis, with a possible statin (HMG-CoA reductase inhibitor) side effect, and a lipid profile showing elevated Low-Density Lipoprotein (LDL) cholesterol, non-High-Density Lipoprotein (non-HDL) cholesterol, and triglycerides, to prevent future pancreatitis events?
What is the management of sarcoidosis-associated uveitis?
Can hyperglycemia (elevated blood glucose), indicated by a fasting blood glucose of 153 mg/dL and a Hemoglobin A1c (HbA1c) of 5.7%, along with hypogonadism (low testosterone) of 153 ng/dL, cause elevated Follicle-Stimulating Hormone (FSH) of 31 mIU/mL and Luteinizing Hormone (LH) of 13.7 mIU/mL in a 51-year-old male?
What is the chronotropic (heart rate) response?
What are the recent developments in uveitis (inflammation of the uvea)?
What are the moderate risk factors for preeclampsia (pregnancy-induced hypertension)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.